The Motley Fool

Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $3.07
Prev Close: $2.97
Open: $2.97
Bid: $3.06
Ask: $3.13
Day's Range: $2.95 - $3.11
52wk Range: $1.76 - $4.67
Volume: 1,813,093
Avg Vol 3,516,040
Market Cap: $485M
P/E (ttm): -12.38
EPS (ttm): ($0.24)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GERN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 3 out of 5
639 Outperform
60 Underperform
CAPS All Stars
91 Outperform
18 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Scarlett, CEO

100% Approve

Based on 2 Ratings

More Details for GeronJobs

Powered by

More Details about Geron Corp

Primary metrics and data points about Geron Corp.